ApoE4: an emerging therapeutic target for Alzheimer ’s disease

The growing body of evidence indicating the heterogeneity of Alzheimer ’s disease (AD), coupled with disappointing clinical studies directed at a fit-for-all therapy, suggest that the development of a single ma...

Source: BMC Medicine - March 20, 2019 Category: Internal Medicine Authors: Mirna Safieh, Amos D. Korczyn and Daniel M. Michaelson Tags: Review Source Type: research